I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 23% ± 8% | |
| glutamatergic neuron | 9 studies | 38% ± 26% | |
| oligodendrocyte | 9 studies | 26% ± 9% | |
| astrocyte | 8 studies | 31% ± 12% | |
| epithelial cell | 6 studies | 31% ± 10% | |
| GABAergic neuron | 6 studies | 40% ± 21% | |
| interneuron | 6 studies | 35% ± 25% | |
| endothelial cell of lymphatic vessel | 5 studies | 20% ± 4% | |
| microglial cell | 5 studies | 23% ± 7% | |
| oligodendrocyte precursor cell | 5 studies | 29% ± 12% | |
| macrophage | 5 studies | 22% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 1% | |
| neuron | 4 studies | 26% ± 10% | |
| adipocyte | 4 studies | 19% ± 2% | |
| fibroblast | 4 studies | 20% ± 5% | |
| smooth muscle cell | 4 studies | 19% ± 2% | |
| natural killer cell | 3 studies | 18% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 1% | |
| ciliated cell | 3 studies | 19% ± 2% | |
| lymphocyte | 3 studies | 24% ± 4% | |
| dendritic cell | 3 studies | 23% ± 8% | |
| granule cell | 3 studies | 25% ± 6% |
